Hybrid Solar Photoelectro-Fenton and Ozone Processes for the Sustainable Removal of COVID-19 Pharmaceutical Contaminants
At a Glance
Section titled âAt a Glanceâ| Metadata | Details |
|---|---|
| Publication Date | 2025-10-10 |
| Journal | Processes |
| Authors | Sonia Herrera-ChĂĄvez, MartĂn PachecoâĂlvarez, Luis A. GodıÌnez, Enric Brillas, Juan M. PeraltaâHernĂĄndez |
| Institutions | Universidad de Guanajuato, Tecnológico Nacional de México |
| Analysis | Full AI Review Included |
Executive Summary
Section titled âExecutive SummaryâThis research demonstrates the high efficiency and sustainability of a hybrid solar photoelectro-Fenton (SPEF) system coupled with ozonation (O3) for the pilot-scale removal of pharmaceutical contaminants related to COVID-19 treatment.
- Core Value Proposition: The hybrid SPEF/O3 system provides a scalable, sustainable, and highly effective Advanced Oxidation Process (EAOP) for treating complex water matrices contaminated with recalcitrant pharmaceuticals, leveraging abundant solar energy.
- Model Pollutant Performance: Complete degradation (100%) of paracetamol (20 mg L-1) was achieved in approximately 50 min using the SPEF process under optimal conditions (j = 60 mA cm-2).
- Mineralization Efficiency: The SPEF process achieved a significant 78% Chemical Oxygen Demand (COD) reduction for paracetamol within 90 min, confirming high mineralization capacity despite the formation of persistent intermediates (catechol, phenol).
- Energy Consumption: The process demonstrated a low specific energy consumption (ECCOD) of 0.0519 kWh (g COD)-1, highlighting its economic viability compared to traditional EAOPs.
- Hybrid System Performance: When treating a four-drug mixture (dexamethasone, paracetamol, amoxicillin, azithromycin), the SPEF/O3 system significantly outperformed standalone O3/sunlight, achieving nearly 60% total drug degradation and 41% COD abatement in 180 min.
- Technology Readiness: The pilot plant utilizes commercially available components (BDD electrodes, CPC photoreactors, ozone generator), enhancing its potential for replication and large-scale implementation in developing countries.
Technical Specifications
Section titled âTechnical Specificationsâ| Parameter | Value | Unit | Context |
|---|---|---|---|
| Reactor Type | CPC Photoreactor | N/A | Compound Parabolic Collector |
| Working Volume | 30 | L | Total solution volume |
| Electrode Configuration | BDD/BDD | N/A | Boron-Doped Diamond (Anode/Cathode) |
| Electrode Area | 64 | cm2 | Geometric area (each electrode) |
| Optimal Current Density (j) | 60 | mA cm-2 | Selected for SPEF trials |
| Electrolysis Time (Standard) | 90 | min | Based on solar irradiance profile |
| UV-A Irradiance (Natural) | 30-35 | W m-2 | Measured during summer trials |
| Operating Temperature | 27 | °C | Controlled via heat exchangers |
| Supporting Electrolyte | 0.05 | M | Na2SO4 |
| Fenton Catalyst | 0.5 | mM | Fe2+ |
| Optimal pH | 3.0 | N/A | Required for Fenton chemistry |
| H2O2 Accumulation (Max) | ~3.0 | mM | Achieved at j = 60 mA cm-2 |
| Paracetamol Initial Concentration | 20 or 50 | mg L-1 | Model pollutant concentration |
| Mixture Initial Concentration (Total) | 116.25 | mg L-1 | Sum of 4 drugs (Dexamethasone, Paracetamol, Amoxicillin, Azithromycin) |
| Paracetamol Degradation | 100 | % | Achieved in ~50 min (SPEF) |
| Paracetamol COD Removal | 78 | % | Achieved in 90 min (SPEF) |
| Specific Energy Consumption (ECCOD) | 0.0519 | kWh (g COD)-1 | SPEF process at 90 min |
| Mixture Degradation (SPEF/O3) | Nearly 60 | % | Total drug concentration (180 min) |
| Mixture COD Abatement (SPEF/O3) | 41 | % | Total COD (180 min) |
Key Methodologies
Section titled âKey Methodologiesâ- Pilot Plant Setup: A continuous flow system was constructed using a 30 L reservoir, a centrifugal pump (300 L h-1 flow rate), a filter-press electrochemical cell (BDD/BDD electrodes), a 15 L CPC-type photoreactor (DURANÂź glass tubes), and an ozone generator (7 L min-1 maximum capacity).
- Electrode Pretreatment: BDD electrodes were activated by applying a high current density (100 mA cm-2) in 0.05 M Na2SO4 solution for 120 min to ensure optimal electrochemical performance.
- SPEF Operating Conditions: Experiments were run at pH 3.0, maintained by H2SO4, using 0.05 M Na2SO4 as the supporting electrolyte and 0.5 mM Fe2+ as the catalyst. A constant current density of 60 mA cm-2 was applied for 90 min under natural solar irradiation.
- H2O2 Electrogeneration: Hydrogen peroxide was continuously generated in situ at the BDD cathode via oxygen reduction, facilitated by the cascade water flow ensuring oxygen saturation.
- SPEF/O3 Hybridization: For mixture trials, the SPEF process was combined with continuous ozone gas bubbling (5 L min-1 flow rate) introduced via a glass diffuser into the CPC photoreactor.
- Analytical Characterization:
- Drug concentrations and aromatic intermediates (catechol, phenol) were quantified using High-Performance Liquid Chromatography (HPLC) with a Supelco C18 column and UV detection at 245 nm.
- H2O2 accumulation and Faradaic efficiency were determined by UV-Vis titration with titanium (IV) oxysulfate.
- Mineralization extent and energy consumption were calculated based on Chemical Oxygen Demand (COD) assays.
Commercial Applications
Section titled âCommercial ApplicationsâThe hybrid solar photoelectro-Fenton (SPEF/O3) technology, relying on BDD electrodes and solar energy, is highly relevant for sustainable water remediation across several sectors:
- Municipal Wastewater Treatment: Effective removal of Contaminants of Emerging Concern (CECs), particularly persistent pharmaceuticals and antibiotics, ensuring cleaner discharge into surface waters.
- Pharmaceutical Manufacturing Effluent: High-efficiency degradation of complex, high-concentration drug mixtures that are recalcitrant to conventional biological treatment.
- Decentralized Water Remediation: The use of solar energy and CPC photoreactors makes this technology ideal for deployment in remote or developing regions where grid power is limited, promoting sustainable water reuse.
- Advanced Oxidation Processes (AOPs) Integration: Provides a robust, synergistic alternative to standalone ozonation or UV-based AOPs, offering enhanced mineralization and reduced energy costs due to solar assistance.
- BDD Electrode Technology: Confirms the viability and robustness of BDD electrodes in pilot-scale EAOPs for generating powerful oxidizing species (hydroxyl radicals) over extended operational periods.
View Original Abstract
This study explores a hybrid advanced electrochemical oxidation process (EAOP) intensified by solar irradiation and ozone for the treatment of wastewater containing COVID-19-related pharmaceuticals. Pilot-scale trials were performed in a 30 L compound parabolic collector (CPC)-type photoreactor with a boron-doped diamond (BDD-BDD) electrode configuration. Under optimal conditions (50 mg Lâ1 paracetamol, 0.05 M Na2SO4, 0.50 mM Fe2+, pH 3.0, and 60 mA cmâ2), the solar photoelectro-Fenton (SPEF) process achieved 78% chemical oxygen demand (COD) reduction within 90 min, with catechol and phenol detected as the main aromatic intermediates. When applied to a four-drug mixture (dexamethasone, paracetamol, amoxicillin, and azithromycin), the solar photoelectro-Fenton (SPEF-ozone (O3)) system reached 60% degradation and 41% COD removal under solar conditions. The results highlight the synergistic effect of ozone and solar energy in enhancing the electrochemical oxidation process (EAOP) performance and demonstrate the potential of these processes for scalable and sustainable removal of pharmaceutical contaminants from wastewater.
Tech Support
Section titled âTech SupportâOriginal Source
Section titled âOriginal SourceâReferences
Section titled âReferencesâ- 2020 - COVID-19 in patients on maintenance dialysis in the Paris region [Crossref]
- 2021 - Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic [Crossref]
- 2024 - A qualitative exploration of purchasing, stockpiling, and use of drugs during the COVID-19 pandemic in an urban city of Bangladesh [Crossref]
- 2022 - Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic [Crossref]
- 2023 - Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study [Crossref]
- 2021 - Effects of acetaminophen on outcomes in patients hospitalized with COVID-19 [Crossref]
- 2021 - Photo-mediated and advanced oxidative processes applied for the treatment of effluents with drugs used for the treatment of early COVID-19: Review [Crossref]
- 2022 - Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environment [Crossref]
- 2021 - Automedicação e uso indiscriminado de medicamentos durante a pandemia da COVID-19 [Crossref]
- 2022 - ParacetamolâA contaminant of high concern: Existence in environment and adverse effect